MRSA in End-of-life care (M-EndoL)

Palliative Medicine

Head of Department:
Prof. Dr. med. Christoph Ostgathe

Multidrug-resistant bacterial microorganisms (MDRO) in end-of-life care: development of recommendations for hospitalized patients using a patient-, family-, and team-centered approach

Little is known about the effects that MRSA colonization and/or infection and the respective isolation measures have on end-of-life patients’ quality of life and the health-related outcomes for the family members as well as on job satisfaction and work load of staff. The interdisciplinary multi-center study “MRSA in end-of-life care (MendoL)” used a mixed methods approach. The working group succeeded in developing patient-, family-, and team-centered recommendations for hospitalized patients at their end of life. This approach has been developed taking into account the heterogeneous views of the four groups involved, patients, family caregivers, staff members and institutional stakeholders. Effects for the individual were taken into account. The recommendation offers an empirical based approach on MDRO management and is available in German for download. The recommendations are available in English in the publication: Heckel, M., et al. (2018). "Multidrug-resistant bacterial microorganisms (MDRO) in end-of-life care: development of recommendations for hospitalized patients using a mixed-methods approach." Support Care Cancer 26(9): 3021-3027.

BMBF (Förderkennzeichen 01GY1314) (Projektlaufzeit: 1.1.2014-30.09.2016)

 The study was funded by the BMBF 

Project Staff:
C. Ostgathe, S. Stiel, M. Heckel, (Lehrstuhl für Palliativmedizin, Comprehensive Cancer Center CCC Erlangen-EMN, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg) 
F. Lang, J. Tiedtke (Lehrstuhl für Psychogerontologie, Friedrich-Alexander-Universität Erlangen-Nürnberg)
C. Bogdan, (Lehrstuhl für Medizinische Mikrobiologie und Infektionsimmunologier klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg)
C. Sieber, A. Sturm (Lehrstuhl für Biomedizin des Alterns, Friedrich-Alexander-Universität Erlangen-Nürnberg)
O. Schöffski, T. Adelhardt (Lehrstuhl für Gesundheitsmanagement, Friedrich-Alexander-Universität Erlangen-Nürnberg